Probiotics in the Management of Ulcerative Colitis

Yazar: Fedorak, Richard N.
Baskı/Yayın Bilgisi 2010

Probiotic Therapies for IBD

Yazar: Fedorak, Richard N.
Baskı/Yayın Bilgisi 2007

Exercise and inflammatory bowel disease

Yazar: Narula, Neeraj, Fedorak, Richard N
Baskı/Yayın Bilgisi 2008

Does smoking reduce infliximab’s effectiveness against Crohn’s disease?

Yazar: Narula, Neeraj, Fedorak, Richard N
Baskı/Yayın Bilgisi 2009

Systematic review of stimulant and nonstimulant laxatives for the treatment of functional constipation

Yazar: Paré, Pierre, Fedorak, Richard N
Yayımlandı Can J Gastroenterol Hepatol (2014)

Probiotics in the Management of Inflammatory Bowel Disease

Yazar: Penner, Robert M., Fedorak, Richard N.
Baskı/Yayın Bilgisi 2005

Predicting, treating and preventing postoperative recurrence of Crohn’s disease: The state of the field

Yazar: Borowiec, Anna M, Fedorak, Richard N
Baskı/Yayın Bilgisi 2011

Gastric intramural hematoma: A case report and literature review

Yazar: Dhawan, Vivek, Mohamed, Ahmed, Fedorak, Richard N
Baskı/Yayın Bilgisi 2009

Canadian Digestive Health Foundation Public Impact Series. Inflammatory bowel disease in Canada: Incidence, prevalence, and direct and indirect economic impact

Yazar: Fedorak, Richard N, Wong, Karen, Bridges, Ron
Baskı/Yayın Bilgisi 2010

Oropharyngeal Crohn’s disease

Yazar: Mohamed, Rachid, Schultz, Robert, Fedorak, Richard N
Baskı/Yayın Bilgisi 2008

Varicella zoster meningitis complicating combined anti-tumor necrosis factor and corticosteroid therapy in Crohn’s disease

Yazar: Ma, Christopher, Walters, Brennan, Fedorak, Richard N
Baskı/Yayın Bilgisi 2013

Adalimumab for orbital myositis in a patient with Crohn’s disease who discontinued infliximab: a case report and review of the literature

Yazar: Verma, Sanam, Kroeker, Karen I, Fedorak, Richard N
Baskı/Yayın Bilgisi 2013

Systematic Review: Non-medical Switching of Infliximab to CT-P13 in Inflammatory Bowel Disease

Yazar: Bernard, Edmond-Jean, Fedorak, Richard N., Jairath, Vipul
Yayımlandı Dig Dis Sci (2020)

Canadian Digestive Health Foundation Public Impact Series: Gastroesophageal reflux disease in Canada: Incidence, prevalence, and direct and indirect economic impact

Yazar: Fedorak, Richard N, van Zanten, Sander Veldhuyzen, Bridges, Ron
Baskı/Yayın Bilgisi 2010

Canadian Digestive Health Foundation Public Impact Series 5: Pancreatitis in Canada. Incidence, prevalence, and direct and indirect economic impact

Yazar: Teshima, Christopher W, Bridges, Ronald J, Fedorak, Richard N
Baskı/Yayın Bilgisi 2012

Canadian Digestive Health Foundation Public Impact Series 4: Celiac disease in Canada. Incidence, prevalence, and direct and indirect economic impact

Yazar: Fedorak, Richard N, Switzer, Connie M, Bridges, Ron J
Baskı/Yayın Bilgisi 2012

Distance management of inflammatory bowel disease: Systematic review and meta-analysis

Yazar: Huang, Vivian W, Reich, Krista M, Fedorak, Richard N
Baskı/Yayın Bilgisi 2014

Clinicians’ guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel disease

Yazar: Bressler, Brian, Panaccione, Remo, Fedorak, Richard N, Seidman, Ernest G
Yayımlandı Can J Gastroenterol Hepatol (2015)

Increased risk of colorectal cancer in ulcerative colitis patients diagnosed after 40 years of age

Yazar: Karvellas, Constantine J, Fedorak, Richard N, Hanson, John, Wong, Clarence KW
Baskı/Yayın Bilgisi 2007

A Machine-Learned Predictor of Colonic Polyps Based on Urinary Metabolomics

Yazar: Eisner, Roman, Greiner, Russell, Tso, Victor, Wang, Haili, Fedorak, Richard N.
Baskı/Yayın Bilgisi 2013